abstract |
The present invention describes immunogenic compositions comprising S. pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. . The invention also describes vaccines, vaccine preparation methods and the use of the vaccines. |